RESOLVE | Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe (RESOLVE)
01-04-2024
-31-03-2029
Show more information
Organisation
OSHO, OSTDEUTSCHE STUDIENGRUPPE HAMATOLOGIE UND ONKOLOGIE E.V.